K

Kelonia Therapeutics

41 employees

Kelonia Therapeutics is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Genetics
Medical

Date founded

2017

Funding rounds raised

Total raised

$50M

from 3 investors over 3 rounds

K

Kelonia Therapeutics raised $50M on April 28, 2022

Investors: Venrock, Alta Partners and Horizons Ventures

FAQ